asthma, bronchial hyperreactivity Asthma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: CIRCUS cohort (n=300) -4 to 18 years old -patient at the children*s department at Medisch Spectrum Twente at moment of inclusion -diagnosed with asthma by a pediatrician following the Global Initiative for Asthma(GINA) guidelines 2022: Medical history fitting asthma diagnosis: Based on (typical) symptoms: (nighttime) wheezing, dyspnea, coughing (triggered by either viral infections, exercise, allergens or weather changes) (Possibly) supplemented with a family history/atopy AND Spirometry variable expiratory airflow limitation by at least one of these criteria: FEV1/FVC reduced compared to lower limit of normal(Z-score 12%) Positive Exercise Challenge Test (ECT)(decrease FEV1>= 13%) Excessive variation in lung function (LF) between tests from different dates (variation FEV1>12% pred) For the MIME intervention (n=106, of which 30 intervention group, 76 control group): • Participating in CIRCUS cohort & consented willingness to participate in interventions. • ACT
Exclusion criteria
Exclusion criteria: For the CIRCUS cohort: The child and/or parent(s) has/have insufficient command of the Dutch language resulting in the insufficient ability to understand and/or answer questions For the MIME study: • An appointment with the asthma nurse for inhalation instruction has already been scheduled.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CIRCUS: Primary outcome measures are Quality of life(QoL), asthma outcomes(asthma control, lung function), quality of care, selfmanagement capacity, healthcare use, and therapy compliance.Intervention 1 MIME: Asthma control, measured by the childhood Asthma control Test (if partidipant < 12 jaar) or the Astma Control Test (if participant >12 jaar) score. | — |
Secondary
| Measure | Time frame |
|---|---|
| CIRCUS: n/aIntervention 1 MIME: The secondary endpoint is the inhalation technique score within the intervention group, intervention adherence, intervention duration and participation rate. | — |
Countries
Netherlands
Contacts
Medisch Spectrum Twente (MST)